For the Culture By The Culture. ISSN: 3064-9331.
Uncover how the Biden administration’s reclassification of cannabis might save businesses millions and spur a rush of investment, but also stoke fears of big pharma and tobacco dominance in the burgeoning market
Dive into the life and cause of Bill Levin, the indomitable spirit behind Indianapolis's First Church of Cannabis. Discover how this church challenges state laws and promotes a unique blend of spirituality and cannabis advocacy
Dive into the celebration of Cinco de Mayo and its bold parallels with the cannabis legalization movement. Uncover how these twin battles against cultural and legal prohibition reflect a broader fight for freedom and change. It's not just a day for margaritas—it's a rallying cry for resistance
Explore how the Biden administration's proposal to reclassify marijuana could unlock new research opportunities and transform the regulatory landscape in Mississippi. Image: Suggested image of a research lab with cannabis plants in focus, capturing the essence of new beginnings in cannabis research
The U.S. is on the brink of reclassifying marijuana as a Schedule III substance, acknowledging its medical benefits while reshaping the landscape for research, taxation, and public perception. Discover the implications of this pivotal change in our detailed analysis
As rumors swirl about a potential DEA announcement to reschedule cannabis, the implications for medical research and industry regulations could be transformative. Will the DEA's decision ignite a new era for cannabis in America? Stay tuned for a groundbreaking shift in drug policy dynamics.
